| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |